Oral Enoximone Pharmacokinetics in Patients with Congestive Heart Failure
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
A physiological approach to hepatic drug clearance
1975 • 1,855 citations
Bioavailability -- A Problem in Equivalence
1974 • 620 citations
New Positive Inotropic Agents in the Treatment of Congestive Heart Failure
1986 • 337 citations
General Treatment of Linear Mammillary Models with Elimination from any Compartment as Used in Pharmacokinetics
1972 • 198 citations
Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure.
1984 • 170 citations
Pharmacokinetics in the aged: A review
1975 • 158 citations
Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics.
1981 • 106 citations
MDL 17,043 therapy in severe congestive heart failure: Characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response
1985 • 58 citations
Influence of volume shifts on drug binding during equilibrium dialysis: Correction and attenuation
1983 • 56 citations
Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy
1986 • 42 citations
Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure
1984 • 36 citations
Hemodynamic Effects of MDL 17,043, a New Cardiotonic Agent, in Patients with Congestive Heart Failure
1983 • 34 citations
Theophylline elimination in congestive heart failure
1983 • 24 citations
Simultaneous analysis of a new cardiotonic agent, MDL 17,043, and its major sulfoxide metabolite in plasma by high-performance liquid chromatography
1984 • 20 citations
Kinetics of fenoximone, a new cardiotonic, in healthy subjects
1984 • 16 citations